Tampa General Hospital announces strategic partnership with Philips to innovate and improve patient experience

NEXT STORY
$3.2 Billion Worldwide Medical Microbiology Testing Technologies Industry to 2027 – Impact of COVID-19 on the Market
PREV STORY
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3772271
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19

author_avatar
NASDAQ Market News

Forty Seven Inc. to Report First Quarter 2019 Financial Results on Monday, May 13, 2019

author_avatar
NASDAQ Market News

Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR®

VICTORIA, British Columbia, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...

author_avatar
NASDAQ Market News